Skip to main content

NEXTBio Capital Management LP

13F filer · CIK 0002038158
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$217MU.S. long equity reported on 13F
Positions223 new · 5 closed
Net flow last quarter-$19.2MBuys minus sells
Top 10 positions weight77.7%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202622 positions
PTGXProtagonist Therapeutics, Inc$26.9M12.37%0.34%-4.5%Q4 2025
STTKShattuck Labs, Inc.$25.9M11.90%3.70%+18.3%Q4 2025
CMPSCOMPASS Pathways plc$25.1M11.56%1.31%-12.2%Q4 2025
GPCRStructure Therapeutics Inc.$16.8M7.71%0.15%+134.5%Q4 2025
VORVor Biopharma Inc.$16.4M7.53%1.63%-11.1%Q4 2025
RYTMRhythm Pharmaceuticals, Inc.$14.6M6.73%0.19%+4.5%Q4 2025
PVLAPalvella Therapeutics, Inc.$13.7M6.32%0.62%+8.7%Q4 2025
XENEXenon Pharmaceuticals Inc.$11.1M5.09%0.19%Not reportedQ4 2025
ZBIOZenas BioPharma, Inc.$10.8M4.98%0.67%Not reportedQ4 2025
ORICOric Pharmaceuticals, Inc.$7.65M3.52%0.68%+34.9%Q4 2025
IVAInventiva S.A.$6.76M3.11%0.93%+34.1%Q4 2025
CBIOCrescent Biopharma, Inc.$6.71M3.09%1.34%Not reportedQ4 2025
PCVXVaxcyte, Inc.$6.23M2.87%0.07%+12.6%Q4 2025
COGTCogent Biosciences, Inc.$5.07M2.33%0.08%-0.1%Q4 2025
VSTMVerastem, Inc.$4.99M2.30%1.44%Not reportedQ4 2025
IRONDisc Medicine, Inc.$3.85M1.77%0.14%Not reportedQ4 2025
PHVSPharvaris N.V.$3.74M1.72%0.17%NewQ2 2026
ZLABZai Lab Ltd$3.48M1.60%0.02%Not reportedQ4 2025
BIOABioAge Labs, Inc.$2.47M1.14%0.22%NewQ2 2026
LBRXLB Pharmaceuticals Inc$2.22M1.02%0.24%NewQ2 2026
EVMNEvommune, Inc.$1.58M0.73%0.33%-35.3%Q4 2025
ACETAdicet Bio, Inc.$1.36M0.63%1.69%Not reportedQ4 2025
Q1 2026Reported May 14, 202624 positions
TERNTerns Pharmaceuticals, Inc.$31.9M14.80%0.52%+9.7%Q4 2025
PTGXProtagonist Therapeutics, Inc$24.2M11.24%0.36%Not reportedQ4 2025
STTKShattuck Labs, Inc.$20.3M9.40%4.17%Not reportedQ4 2025
VORVor Biopharma Inc.$17.8M8.28%1.85%Not reportedQ4 2025
CMPSCOMPASS Pathways plc$11.2M5.19%1.50%+168.6%Q4 2025
RYTMRhythm Pharmaceuticals, Inc.$11M5.09%0.18%+86.5%Q4 2025
XENEXenon Pharmaceuticals Inc.$10.7M4.95%0.19%-0.3%Q4 2025
PVLAPalvella Therapeutics, Inc.$10.3M4.79%0.58%Not reportedQ4 2025
ZBIOZenas BioPharma, Inc.$8.34M3.87%0.68%+32.5%Q4 2025
IVAInventiva S.A.$7.4M3.44%0.69%+2.7%Q4 2025
VSTMVerastem, Inc.$6.93M3.22%1.49%0.0%Q4 2025
CBIOCrescent Biopharma, Inc.$6.85M3.18%1.35%Not reportedQ4 2025
ORICOric Pharmaceuticals, Inc.$6.63M3.08%0.51%-15.0%Q4 2025
GPCRStructure Therapeutics Inc.$6.42M2.98%0.06%+41.1%Q4 2025
PCVXVaxcyte, Inc.$5.53M2.57%0.07%-0.3%Q4 2025
COGTCogent Biosciences, Inc.$5.05M2.34%0.08%+36.9%Q4 2025
CMPXCompass Therapeutics, Inc.$4.49M2.08%0.47%-23.9%Q4 2025
EVMNEvommune, Inc.$4.23M1.96%0.51%-19.4%Q4 2025
OCSOculis Holding AG$3.98M1.85%Not reported-0.1%Q4 2025
ZLABZai Lab Ltd$3.45M1.60%0.02%+12.2%Q4 2025
IRONDisc Medicine, Inc.$3.37M1.56%0.14%+23.1%Q4 2025
KALVKalVista Pharmaceuticals, Inc.$2.65M1.23%0.26%Not reportedQ4 2025
SMMTSummit Therapeutics Inc.$1.7M0.79%0.01%NewQ1 2026
ACETAdicet Bio, Inc.$1.07M0.50%1.64%Not reportedQ4 2025
Q4 2025Reported Feb 13, 202623 positions
TERNTerns Pharmaceuticals, Inc.$22.3M13.06%0.49%NewQ4 2025
PTGXProtagonist Therapeutics, Inc$20.1M11.76%0.37%NewQ4 2025
VORVor Biopharma Inc.$13.1M7.67%2.58%NewQ4 2025
ZBIOZenas BioPharma, Inc.$11.7M6.86%0.59%NewQ4 2025
STTKShattuck Labs, Inc.$11.5M6.74%4.98%NewQ4 2025
VSTMVerastem, Inc.$10.1M5.92%1.68%NewQ4 2025
PVLAPalvella Therapeutics, Inc.$8.65M5.08%0.67%NewQ4 2025
XENEXenon Pharmaceuticals Inc.$8.23M4.83%0.23%NewQ4 2025
RYTMRhythm Pharmaceuticals, Inc.$7.23M4.24%0.10%NewQ4 2025
GPCRStructure Therapeutics Inc.$6.57M3.85%0.04%NewQ4 2025
IVAInventiva S.A.$6.04M3.54%0.67%NewQ4 2025
CMPXCompass Therapeutics, Inc.$5.98M3.51%0.62%NewQ4 2025
CMPSCOMPASS Pathways plc$5.19M3.05%0.78%NewQ4 2025
ORICOric Pharmaceuticals, Inc.$5.04M2.95%0.62%NewQ4 2025
CBIOCrescent Biopharma, Inc.$4.42M2.59%1.35%NewQ4 2025
PCVXVaxcyte, Inc.$4.41M2.58%0.07%NewQ4 2025
EVMNEvommune, Inc.$3.91M2.29%0.72%NewQ4 2025
COGTCogent Biosciences, Inc.$3.4M2.00%0.06%NewQ4 2025
IRONDisc Medicine, Inc.$3.4M1.99%0.11%NewQ4 2025
OCSOculis Holding AG$2.99M1.75%Not reportedNewQ4 2025
ZLABZai Lab Ltd$2.88M1.69%0.01%NewQ4 2025
KALVKalVista Pharmaceuticals, Inc.$2.13M1.25%0.26%NewQ4 2025
ACETAdicet Bio, Inc.$1.33M0.78%1.65%NewQ4 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.